TY - JOUR
T1 - Impaired Barrier Function and Autoantibody Generation in Malnutrition Enteropathy in Zambia
AU - Amadi, Beatrice
AU - Besa, Ellen
AU - Zyambo, Kanekwa
AU - Kaonga, Patrick
AU - Louis-Auguste, John
AU - Chandwe, Kanta
AU - Tarr, Phillip I.
AU - Denno, Donna M.
AU - Nataro, James P.
AU - Faubion, William
AU - Sailer, Anne
AU - Yeruva, Sunil
AU - Brantner, Tricia
AU - Murray, Joseph
AU - Prendergast, Andrew J.
AU - Turner, Jerrold R.
AU - Kelly, Paul
N1 - Funding Information:
Funding was obtained from the Bill & Melinda Gates Foundation (OPP1066118), the Medical Research Council (MR/K012711/1), UK, and CORE (UK). These funding sources played no part in the decision to publish, data analysis, or the writing of the manuscript. No person was paid to contribute to the writing process.
Publisher Copyright:
© 2017
PY - 2017/8
Y1 - 2017/8
N2 - Intestinal damage in malnutrition constitutes a threat to the survival of many thousands of children globally. We studied children in Lusaka, Zambia, with severe acute malnutrition (SAM) and persistent diarrhea using endoscopy, biopsy and analysis of markers and protective proteins in blood and intestinal secretions. We carried out parallel investigations in apparently healthy adults, and analyzed biomarkers only in apparently healthy children. Villus height and crypt depth did not differ in children with SAM and adult controls, but epithelial surface was reduced in children with SAM (median 445, interquartile range (IQR) 388, 562 μm per 100 μm muscularis mucosae) compared to adults (578, IQR 465,709; P = 0.004). Histological lesions and disruptions of claudin-4 and E-cadherin were most pronounced in children with SAM. Circulating lipopolysaccharide, a marker of bacterial translocation, was higher in malnourished children (251, IQR 110,460 EU/ml) than in healthy children (51, IQR 0,111; P = 0.0001). Other translocation markers showed similar patterns. Anti-Deamidated Gliadin Peptide IgG concentrations, although within the normal range, were higher in children with SAM (median 2.7 U/ml, IQR 1.5–8.6) than in adults (1.6, 1.4–2.1; P = 0.005), and were inversely correlated with villus height (ρ = − 0.79, n = 13, P = 0.001). Malnutrition enteropathy is associated with intestinal barrier failure and immune dysregulation.
AB - Intestinal damage in malnutrition constitutes a threat to the survival of many thousands of children globally. We studied children in Lusaka, Zambia, with severe acute malnutrition (SAM) and persistent diarrhea using endoscopy, biopsy and analysis of markers and protective proteins in blood and intestinal secretions. We carried out parallel investigations in apparently healthy adults, and analyzed biomarkers only in apparently healthy children. Villus height and crypt depth did not differ in children with SAM and adult controls, but epithelial surface was reduced in children with SAM (median 445, interquartile range (IQR) 388, 562 μm per 100 μm muscularis mucosae) compared to adults (578, IQR 465,709; P = 0.004). Histological lesions and disruptions of claudin-4 and E-cadherin were most pronounced in children with SAM. Circulating lipopolysaccharide, a marker of bacterial translocation, was higher in malnourished children (251, IQR 110,460 EU/ml) than in healthy children (51, IQR 0,111; P = 0.0001). Other translocation markers showed similar patterns. Anti-Deamidated Gliadin Peptide IgG concentrations, although within the normal range, were higher in children with SAM (median 2.7 U/ml, IQR 1.5–8.6) than in adults (1.6, 1.4–2.1; P = 0.005), and were inversely correlated with villus height (ρ = − 0.79, n = 13, P = 0.001). Malnutrition enteropathy is associated with intestinal barrier failure and immune dysregulation.
KW - Autoantibodies
KW - Enteropathy
KW - Environmental enteric dysfunction
KW - Glucagon-like peptide 2
KW - HIV
KW - Malnutrition
KW - Microbial translocation
KW - Tissue transglutaminase serology, deamidated gliadin peptide serology
UR - http://www.scopus.com/inward/record.url?scp=85025445517&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85025445517&partnerID=8YFLogxK
U2 - 10.1016/j.ebiom.2017.07.017
DO - 10.1016/j.ebiom.2017.07.017
M3 - Article
C2 - 28750860
AN - SCOPUS:85025445517
SN - 2352-3964
VL - 22
SP - 191
EP - 199
JO - EBioMedicine
JF - EBioMedicine
ER -